Skip to content

End-of-life distress: all studies

Page 39 of 40: studies 381 to 390 of 391, newest first. Back to the end-of-life distress overview

Research

Spiritual distress at life's end: finding meaning in the maelstrom.

Journal of Pastoral Care & Counseling 2003 Christine Kennedy, Sharon E Cheston

Recent trends in social research indicate a decline in church attendance and a corresponding increased interest in spirituality. With the aging of the population, attention to end of life care, with its corresponding spiritual concerns and distress, has become a prominent issue. Spiritual distress can be difficult to distinguish from psychological and physical distress and indicates the need...

Analysis of the medical use of marijuana and its societal implications.

Journal of the American Pharmaceutical Association 1998 H G Taylor

To review the pharmacology, therapeutics, adverse effects, and societal implications of the medical use of marijuana. MEDLINE and manual searches of English-language marijuana literature, supplemented with interviews of scientists currently conducting cannabinoid research. Search terms included pain OR palliative care AND cannabis or ALL marijuana; cachexia OR appetite OR appetite stimulants;...

Dreams of the Dying Patient: An Exploration of Content

OMEGA - Journal of Death and Dying August 1, 1991 Pamela N. Prince, Robert Hoffmann 8 citations

This study examined the dreams of eight individuals admitted to the Palliative Care Unit of the Elisabeth Bruyere Health Centre, Ottawa, Canada. Content analysis of the dream reports in this sample supports the hypothesis that a continuity exists between dreaming and waking experience [1]. Results do not indicate that themes of death and aggression, negative emotion, or infant and child...

Toward a nursing theory of self-transcendence: deductive reformulation using developmental theories.

ANS. Advances in nursing science June 1991 P G Reed

The purpose of this article is to explicate the development of an emerging middle-range nursing theory of self-transcendence. The process of developing the theory was based largely on the method of "deductive reformulation." Using this strategy, theoretic knowledge derived from life span developmental psychology was reformulated based on Rogers' conceptual system. Clinical experience and...

Frenquel, a Blocking Agent Against Experimental LSD‐25 and Mescaline Psychosis

Neurology May 1, 1955 Howard D. Fabing 41 citations

Background: Patients with ALS commonly exhibit pseudobulbar affect. Methods: The authors conducted a multicenter, randomized, double-blind, controlled, parallel, three-arm study to test a defined combination of dextromethorphan hydrobromide (DM) and quinidine sulfate (Q) (AVP-923) for the treatment of pseudobulbar affect in ALS. Q inhibits the rapid first-pass metabolism of DM. The effects of...

DOI: 10.1212/wnl.5.5.319 (opens in new tab) Discontinuation Dextromethorphan Randomized controlled trial Adverse effect +2

A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.

Journal of Clinical Psychopharmacology Nicole Ledwos, Joshua D. Rosenblat, Daniel M. Blumberger et al. 16 citations

There has been resurgence of interest in the therapeutic use of serotonergic ("classic") psychedelics in major depressive disorder (MDD) and end-of-life distress. This commentary offers a critical appraisal of current evidence for antidepressant effects of classic psychedelics from contemporary clinical trials and highlights pitfalls that should be addressed before clinical translation. A...

DOI: 10.1097/jcp.0000000000001608 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Mental health treatment Clinical research Depression treatment +1

Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.

Clinical Neuropharmacology Ramiro Manzano-Nunez, Diego A Gomez, Catalina Toledo-Mendoza et al. 3 citations

This scoping review aimed to synthesize the existing data about psilocybin pharmacokinetics to learn what has been described regarding body disposition and safety when psilocybin was used in controlled research settings. We performed a scoping literature review following the framework proposed by the JBI manual for evidence synthesis. Controlled clinical trials reporting pharmacokinetic data of...

Quality of Life and the Case for Consent-Based Psilocybin Access – Questions on the Regulatory Framework and Cost

Janis Ancans preprint

Legal access to psilocybin almost always requires a medical diagnosis first, usually treatment-resistant depression (TRD) or severe PTSD, as though informed consent alone was not sufficient. This article makes two connected arguments. Extending the autonomy argument already accepted for terminally ill patients, competent adults who understand the potential benefits and risks of a psilocybin...